Intranasal Oxytocin in Hypothalamic Obesity

Conditions: Craniopharyngioma; Hypothalamic Obesity Interventions: Drug: Syntocinon; Drug: Placebo (for Syntocinon) Sponsor: Shana McCormack, MD Not yet recruiting - verified July 2016

http://clinicaltrials.gov/ct2/show/NCT02849743?lup_s=07%2F10%2F2016&lup_d=30

Source: ClinicalTrials.gov - July 22, 2016 Category: Research Source Type: clinical trials

More News: Craniopharyngioma | Eating Disorders & Weight Management | Obesity | Research